London Calling 2024 - Speakers
Speakers
Check out the line up of speaking at London Calling 2024.
A
)
Dr. Ahmad Abou TayounAl Jalila Children’s Specialty Hospital & Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, UAE
Antoni P.A. HendrickxNational Institute for Public Health and the Environment, Netherlands
)
Andre HolzerHolzer Scientific Consultancy, Germany
)
Anoushka JoglekarNew York Genome Center, USA
)
Adrien LegerDirector, Modified Base Research, Oxford Nanopore Technologies
)
Alex ShawImperial College London, UK
)
Alex TrotterDevelopment Scientist – Translational Development, Oxford Nanopore Technologies
)
Alexander WittenbergKeyGene, Netherlands
)
Akelia Wauchope-OdumboAssociate Director, Technical Applications — Americas, Oxford Nanopore Technologies
B
)
Bryant CatanoSenior Product Support Scientist, Oxford Nanopore Technologies
)
Prof. Benjamin KippMayo Clinic, USA
)
Bosheng LiInstitute of Advanced Agricultural Sciences, Peking University, China
)
Ben PriceNatural History Museum, UK
C
)
Claire AndersonUniversity College London, UK
)
Chris AlderBioinformatician, Oxford Nanopore Technologies
)
Clive BrownChief Technology, Innovation, and Product Officer, Oxford Nanopore Technologies
)
Chao Chun LiuSimon Fraser University, Canada
Dr. Chuck CooperbioMérieux, France
)
Dr. Charles K. CooperbioMérieux, France
)
Dr. Clemens JakobiLonza, Switzerland
)
Dr. Carolyn TregidgoVP, Late Stage and Applied Product Development, Oxford Nanopore Technologies
D
)
Daniel BrantonHarvard University, USA
)
David W. DeamerUniversity of California, Santa Cruz, USA
Dan FordhamDirector, Strategic Product Management EMEA, Oxford Nanopore Technologies
)
Dr. Danny E. MillerUniversity of Washington, USA
)
Devin OglesbeeMayo Clinic, USA
E
)
Prof. Emma BapleUniversity of Exeter and South West NHS Genomics Laboratory Hub, UK
)
Ethan Hill‘Iolani School, USA
)
Emma WhiteVP, Marketing Operations, Oxford Nanopore Technologies
)
Eddy de BoerUniversity Medical Center Groningen, Netherlands
)
H
)
Dr. Helen Bulbeckbrainstrust, UK
)
Hagan BayleyUniversity of Oxford, UK
)
Dr. Helen GunterBASE mRNA Facility, The University of Queensland, Australia
)
Hanlee JiStanford University, USA
)
Heather Ritchie-ParkerRoyal Zoological Society of Scotland, UK
I
)
Prof. Ian AbbsGuy’s and St Thomas’ NHS Foundation Trust, UK
)
Dr. Inès HassanTony Blair Institute for Global Change, UK
J
)
Jessica AndersonSenior Field Applications Scientist, Oxford Nanopore Technologies
)
Prof. Sir John BellEllison Institute of Technology Oxford, UK
)
Jimmy CreithField Applications Scientist, Bioinformatics, Oxford Nanopore Technologies
)
Julie DragonUniversity of Vermont, USA
)
Dr. Janessa LaskinBC Cancer Centre & University of British Columbia, Canada
)
Joanne TrinhInstitute of Neurogenetics, Germany
)
Prof. Joris VermeeschKU Leuven, Belguim
)
Jose-Crispin Zavala AlvaradoPathoQuest, France
K
)
Kimberley BillingsleyNational Institutes of Health, USA
)
Kara DicksProgramme Manager, Conservation Genomics—ORG.ONE, Oxford Nanopore Technologies
)
Dr. Karen SherwoodUniversity of British Columbia, Canada
)
Katharina WolffTU Braunschweig, Germany
L
)
Lyn ChittyGreat Ormond Street NHS Foundation Trust & UCL Great Ormond Street Institute of Child Health, UK
)
Lauren LuiLawrence Berkeley National Laboratory, USA
)
Dr. Luke W. MeredithWHO-EMRO World Health Emergencies, Egypt
)
Dr. Luca MazzarellaEuropean Institute of Oncology, Italy
)
Prof. Laurent MesnardSorbonne University, France
)
Lorey SmithPeter MacCallum Cancer Centre, Australia
)
Lara UrbanHemholtz AI, Germany
M
)
Medini AnnavajhalaColumbia University Irving Medical Center, USA
)
Mark AkesonUniversity of California, Santa Cruz, USA
)
Prof. Matt BrownGenomics England, UK
)
Morgan GueuningBlood Transfusion Service, Switzerland
)
Morghan LucasMedical Genetics Center, Germany
Michael NakaiPeter MacCallum Cancer Centre, Australia
)
Dr. Matt ParkerDirector, Clinical Bioinformatics Software, Oxford Nanopore Technologies
)
Mile SikicGenome Institute of Singapore, A*STAR, Singapore
)
Mrinalini WatsaSan Diego Zoo Wildlife Alliance, USA
N
)
Natalia GarciaBioinformatics Workflow Developer, Oxford Nanopore Technologies
)
Ndack NdiayePasteur Institute, Senegal
)
Nick SeddonOptum Genomics, USA
P
)
Paul ArvidsonGenomics England & SWAN, UK
)
Ping LuPeking University, China
)
Prof. Dr. Pieter WesselingPrincess Máxima Center for Pediatric Oncology & Amsterdam University Medical Centers, The Netherlands
R
)
Dr. Rahul BatraGuy's & St Thomas' Hospital NHS Trust, UK
)
Rui ChenBaylor College of Medicine, USA
)
Rea KobialkaInstitute of Animal Hygiene and Veterinary Public Health, Germany
)
Rachel RubinsteinManager, Software Technical Product Management, Oxford Nanopore Technologies
)
Rosemary Sinclair DokosSVP, Product and Programme Management, Oxford Nanopore Technologies
)
Rhys WhiteInstitute of Environmental Science and Research, New Zealand
S
)
Sergey BatalovRady Children’s Institute for Genomic Medicine, USA
)
Seanne P. BuckwalterMayo Clinic, USA
)
Sam DavisPrincipal Scientist, Machine Learning, Oxford Nanopore Technologies
)
Sneha GoenkaStanford University & Princeton University, USA
)
Sarah GriffithsBioinformatics Workflow Developer, Oxford Nanopore Technologies
)
Sirisha HeskethClinical Bioinformatician, Oxford Nanopore Technologies
Sofia KudashevaEarlham Institute, UK
)
Susie LeeTechnical Product Manager, Basecalling and Models, Oxford Nanopore Technologies
)
Sean McKenzieAssociate Director, Genomic Applications Bioinformatics, Oxford Nanopore Technologies
)
Dr. Simon PaineNottingham University Hospitals NHS Trust, UK
)
Steph WilbrahamDirector, Automation Product Management, Oxford Nanopore Technologies
)
Spike WillcocksChief Strategy Officer, Oxford Nanopore Technologies
T
)
Thias Oberg BoesenNovo Nordisk A/S, Denmark
)
Tomás Di DomenicoNational Cancer Research Center, Spain
)
Tomasz DobrzyckiField Applications Scientist, New Product Introduction, Oxford Nanopore Technologies
)
Dr. Telmo GraçaLonza, Switzerland
)
Tina HanTwist Bioscience
)
Dr. Thomas R. KreilTakeda, Austria
)
Tetyana VasylyevaUniversity of California, Irvine, USA
)
)
)
Oxford Nanopore Technologies
Prof. Ian Abbs
)
- Job title
- Institution
- Guy’s and St Thomas’ NHS Foundation Trust, UK
- Biography
Ian is the CEO of Guy's and St Thomas’ NHS Foundation Trust and leads the largest NHS Trust in England, with a turnover of £2.9 billion and 25,000 staff. He has a BSc in Immunology, degrees in Medicine, is a Fellow of the Royal Society of Arts, holds an MBA from the University of Cambridge, and a Professorship in the Faculty of Medicine, Kings College London. Ian plays a key role in the development of the Trust's life- science partnerships and aspects of digital transformation and innovation agenda.